Související články - externí
Všechny
- Effect of nucleoside analog use in patients with hepatitis B virus-related hepatocellular carcinoma. 25. 5. 2013 Medline/PubMed - hepatitida B
- Epigenetic regulation of miR-122 by PPARγ and hepatitis B virus X protein in hepatocellular carcinoma cells. 25. 5. 2013 Medline/PubMed - hepatitida B
- The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in a Chinese population: a meta-analysis. 25. 5. 2013 Medline/PubMed - hepatitida B
- The sequential analysis of amino acid substitutions with hepatitis B virus in association with nucleos(t)ide analogue treatment detecting by deep sequencing. 25. 5. 2013 Medline/PubMed - hepatitida B
- "hepatitis c"[Title]; +17 new citations 25. 5. 2013 Medline/PubMed - hepatitida C
- Hepatitis B prevention and care for asian americans, native hawaiians and pacific islanders at community health centers. 25. 5. 2013 Medline/PubMed - hepatitida B
- Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso. 25. 5. 2013 Medline/PubMed - hepatitida B
- Chronic hepatitis B infection: A global disease requiring global strategies. 25. 5. 2013 Medline/PubMed - hepatitida B
- Low vitamin D serum concentration is associated with high levels of hepatitis B virus (HBV) replication in chronically infected patients. 25. 5. 2013 Medline/PubMed - hepatitida B
- High Levels of HBV after the Onset Lead to Chronic Infection in Patients with Acute Hepatitis B. 25. 5. 2013 Medline/PubMed - hepatitida B
- Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus. 24. 5. 2013 Medline/PubMed - hepatitida C
- Ongoing Risk Behavior and the Presence of HCV-RNA Affect the Hepatitis C Virus (HCV)-Specific CD4(+) T Cell Response. 24. 5. 2013 Medline/PubMed - hepatitida C
- Different requirements for SR-BI in hepatitis C virus cell-free versus cell-to-cell transmission. 24. 5. 2013 Medline/PubMed - hepatitida C
- Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 76 24. 5. 2013 Medline/PubMed - hepatitida C
- SHIP2 regulates epithelial cell polarity through its lipid product that binds to Dlg1, a pathway subverted by Hepatitis C virus core protein. 24. 5. 2013 Medline/PubMed - hepatitida C
- Hepatitis C Virus, Cholesterol and Lipoproteins - Impact for the Viral Life Cycle and Pathogenesis of Liver Disease. 24. 5. 2013 Medline/PubMed - hepatitida C
- NS5ATP9 Contributes to Inhibition of Cell Proliferation by Hepatitis C Virus (HCV) Nonstructural Protein 5A (NS5A) via MEK/Extracellular Signal Regulated Kinase (ERK) Pathway. 24. 5. 2013 Medline/PubMed - hepatitida C
- "hepatitis c"[Title]; +26 new citations 23. 5. 2013 Medline/PubMed - hepatitida C
- HCV Phase III Studies and Approved Agents 13. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- MK-5172 Plus PegIFN/RBV Achieves 86% to 92% SVR24 Rates in Treatment-Naive, Noncirrhotic Patients With Genotype 1 HCV 7. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- High SVR12 Rates With Short-Course (6 or 12 Weeks) of Ledipasvir and GS-9451 Plus PegIFN/RBV Quadruple Therapy in Treatment-Naive, Noncirrhotic Patients With Genotype 1 HCV Infection and <i>IL28B</i> CC Genotype 6. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- Vaniprevir Plus PegIFN/RBV Significantly Increases SVR24 Rate vs PegIFN/RBV Retreatment in Cirrhotic, Genotype 1 HCV–Infected, Previous Nonresponders to PegIFN/RBV 6. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- Daclatasvir Plus Asunaprevir Plus BMS-791325 Achieves ≥ 88% SVR Rates in Noncirrhotic Treatment-Naive Patients With Genotype 1 HCV 3. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- HBV DNA Seroclearance Significantly Reduces Risk of HCC in Patients With High Baseline Viral Loads 2. 5. 2013 Clinical Care Options Hepatitis – Hepatitida B
- CONCISE: Interim Results Show High SVR Rates With Either 12 or 24 Weeks of Telaprevir Plus Peginterferon/Ribavirin in Patients With HCV Genotype 1 and <i>IL28B</i> CC Genotype 2. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- QUEST-1: Simeprevir Plus PegIFN/RBV Significantly Improves SVR12 Rate vs PegIFN/RBV Alone in Treatment-Naive Patients With Genotype 1 HCV 1. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- POSITRON: Sofosbuvir/Ribavirin Superior to Placebo With 78% SVR12 Rate in Genotype 2/3 HCV–Infected Patients Intolerant of, Ineligible for, or Unwilling to Receive IFN 30. 4. 2013 Clinical Care Options Hepatitis – Hepatitida C
- Prolonged Tenofovir-Based Antiviral Therapy Maintains HBV DNA Suppression in Patients With Chronic HBV, Normal ALT Levels, and High HBV DNA Levels 30. 4. 2013 Clinical Care Options Hepatitis – Hepatitida B
- Observed HCC Incidence Lower Than Predicted in Patients With Chronic Hepatitis B Receiving Tenofovir in Phase III Clinical Trials 30. 4. 2013 Clinical Care Options Hepatitis – Hepatitida B
- COMMAND: Daclatasvir Plus PegIFN/RBV Improves SVR24 Rate vs PegIFN/RBV Alone in Treatment-Naive Patients With Genotype 2/3 HCV 30. 4. 2013 Clinical Care Options Hepatitis – Hepatitida C
- FISSION: Sofosbuvir/Ribavirin Noninferior to Peginterferon/Ribavirin for SVR12 in Treatment-Naive Patients With HCV Genotype 2/3 28. 4. 2013 Clinical Care Options Hepatitis – Hepatitida B
- High Rate of Advanced Fibrosis in Patients With HBV/HIV Coinfection, Despite HBV Suppression With Antiretroviral Therapy 26. 4. 2013 Clinical Care Options Hepatitis – Hepatitida B
- ClinicalThought™: Hepatitis Highlights 26. 2. 2013 Clinical Care Options Hepatitis – Hepatitida B
- Highlights From AASLD 2012 3. 12. 2012 Clinical Care Options Hepatitis – Hepatitida B
- Serum HBsAg During Treatment Predicts Response to Peginterferon-Based Therapy in HBeAg-Positive Patients With Chronic Hepatitis B 12. 11. 2012 Clinical Care Options Hepatitis – Hepatitida B
- Joining East and West: Coordinating HBV Management Between Western and Traditional Asian Medicine Practices 4. 10. 2012 Clinical Care Options Hepatitis – Hepatitida B
Clinical Care Options Hepatitis – Hepatitida B
- HBV DNA Seroclearance Significantly Reduces Risk of HCC in Patients With High Baseline Viral Loads 2. 5. 2013 Clinical Care Options Hepatitis – Hepatitida B
- Observed HCC Incidence Lower Than Predicted in Patients With Chronic Hepatitis B Receiving Tenofovir in Phase III Clinical Trials 30. 4. 2013 Clinical Care Options Hepatitis – Hepatitida B
- Prolonged Tenofovir-Based Antiviral Therapy Maintains HBV DNA Suppression in Patients With Chronic HBV, Normal ALT Levels, and High HBV DNA Levels 30. 4. 2013 Clinical Care Options Hepatitis – Hepatitida B
- FISSION: Sofosbuvir/Ribavirin Noninferior to Peginterferon/Ribavirin for SVR12 in Treatment-Naive Patients With HCV Genotype 2/3 28. 4. 2013 Clinical Care Options Hepatitis – Hepatitida B
- High Rate of Advanced Fibrosis in Patients With HBV/HIV Coinfection, Despite HBV Suppression With Antiretroviral Therapy 26. 4. 2013 Clinical Care Options Hepatitis – Hepatitida B
- ClinicalThought™: Hepatitis Highlights 26. 2. 2013 Clinical Care Options Hepatitis – Hepatitida B
- Highlights From AASLD 2012 3. 12. 2012 Clinical Care Options Hepatitis – Hepatitida B
- Serum HBsAg During Treatment Predicts Response to Peginterferon-Based Therapy in HBeAg-Positive Patients With Chronic Hepatitis B 12. 11. 2012 Clinical Care Options Hepatitis – Hepatitida B
- Joining East and West: Coordinating HBV Management Between Western and Traditional Asian Medicine Practices 4. 10. 2012 Clinical Care Options Hepatitis – Hepatitida B
Clinical Care Options Hepatitis – Hepatitida C
- HCV Phase III Studies and Approved Agents 13. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- MK-5172 Plus PegIFN/RBV Achieves 86% to 92% SVR24 Rates in Treatment-Naive, Noncirrhotic Patients With Genotype 1 HCV 7. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- Vaniprevir Plus PegIFN/RBV Significantly Increases SVR24 Rate vs PegIFN/RBV Retreatment in Cirrhotic, Genotype 1 HCV–Infected, Previous Nonresponders to PegIFN/RBV 6. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- High SVR12 Rates With Short-Course (6 or 12 Weeks) of Ledipasvir and GS-9451 Plus PegIFN/RBV Quadruple Therapy in Treatment-Naive, Noncirrhotic Patients With Genotype 1 HCV Infection and <i>IL28B</i> CC Genotype 6. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- Daclatasvir Plus Asunaprevir Plus BMS-791325 Achieves ≥ 88% SVR Rates in Noncirrhotic Treatment-Naive Patients With Genotype 1 HCV 3. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- CONCISE: Interim Results Show High SVR Rates With Either 12 or 24 Weeks of Telaprevir Plus Peginterferon/Ribavirin in Patients With HCV Genotype 1 and <i>IL28B</i> CC Genotype 2. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- QUEST-1: Simeprevir Plus PegIFN/RBV Significantly Improves SVR12 Rate vs PegIFN/RBV Alone in Treatment-Naive Patients With Genotype 1 HCV 1. 5. 2013 Clinical Care Options Hepatitis – Hepatitida C
- POSITRON: Sofosbuvir/Ribavirin Superior to Placebo With 78% SVR12 Rate in Genotype 2/3 HCV–Infected Patients Intolerant of, Ineligible for, or Unwilling to Receive IFN 30. 4. 2013 Clinical Care Options Hepatitis – Hepatitida C
- COMMAND: Daclatasvir Plus PegIFN/RBV Improves SVR24 Rate vs PegIFN/RBV Alone in Treatment-Naive Patients With Genotype 2/3 HCV 30. 4. 2013 Clinical Care Options Hepatitis – Hepatitida C
Medline/PubMed - hepatitida B
- Chronic hepatitis B infection: A global disease requiring global strategies. 25. 5. 2013 Medline/PubMed - hepatitida B
- Epigenetic regulation of miR-122 by PPARγ and hepatitis B virus X protein in hepatocellular carcinoma cells. 25. 5. 2013 Medline/PubMed - hepatitida B
- Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso. 25. 5. 2013 Medline/PubMed - hepatitida B
- Effect of nucleoside analog use in patients with hepatitis B virus-related hepatocellular carcinoma. 25. 5. 2013 Medline/PubMed - hepatitida B
- The sequential analysis of amino acid substitutions with hepatitis B virus in association with nucleos(t)ide analogue treatment detecting by deep sequencing. 25. 5. 2013 Medline/PubMed - hepatitida B
- The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in a Chinese population: a meta-analysis. 25. 5. 2013 Medline/PubMed - hepatitida B
- Hepatitis B prevention and care for asian americans, native hawaiians and pacific islanders at community health centers. 25. 5. 2013 Medline/PubMed - hepatitida B
- High Levels of HBV after the Onset Lead to Chronic Infection in Patients with Acute Hepatitis B. 25. 5. 2013 Medline/PubMed - hepatitida B
- Low vitamin D serum concentration is associated with high levels of hepatitis B virus (HBV) replication in chronically infected patients. 25. 5. 2013 Medline/PubMed - hepatitida B
Medline/PubMed - hepatitida C
- "hepatitis c"[Title]; +17 new citations 25. 5. 2013 Medline/PubMed - hepatitida C
- Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus. 24. 5. 2013 Medline/PubMed - hepatitida C
- SHIP2 regulates epithelial cell polarity through its lipid product that binds to Dlg1, a pathway subverted by Hepatitis C virus core protein. 24. 5. 2013 Medline/PubMed - hepatitida C
- NS5ATP9 Contributes to Inhibition of Cell Proliferation by Hepatitis C Virus (HCV) Nonstructural Protein 5A (NS5A) via MEK/Extracellular Signal Regulated Kinase (ERK) Pathway. 24. 5. 2013 Medline/PubMed - hepatitida C
- Hepatitis C Virus, Cholesterol and Lipoproteins - Impact for the Viral Life Cycle and Pathogenesis of Liver Disease. 24. 5. 2013 Medline/PubMed - hepatitida C
- Different requirements for SR-BI in hepatitis C virus cell-free versus cell-to-cell transmission. 24. 5. 2013 Medline/PubMed - hepatitida C
- Ongoing Risk Behavior and the Presence of HCV-RNA Affect the Hepatitis C Virus (HCV)-Specific CD4(+) T Cell Response. 24. 5. 2013 Medline/PubMed - hepatitida C
- Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 76 24. 5. 2013 Medline/PubMed - hepatitida C
- "hepatitis c"[Title]; +26 new citations 23. 5. 2013 Medline/PubMed - hepatitida C
V hepatologické části sekce Moje
vzdělání najdete jednotlivé audiovizuální
přednášky (webcasty) i celé semináře
natočené s našimi odborníky speciálně pro portál MojeMedicína.
Odborné i organizační informace naleznete v nejnovějších článcích a
aktualitách s hepatologickou tematikou v lékařské databázi
Medline a na portálu Clinical Care
Options (viz související články). Lékařům jsou k dispozici
také informace ke specializačnímu studiu
infekčního lékařství i návody a rady k přípravě na další stupně
vzdělávání.
- Therapeutické oblasti: Hepatologie
